Literature DB >> 3008995

Characterization of growth factors in human ovarian carcinomas.

T Bauknecht, M Kiechle, G Bauer, J W Siebers.   

Abstract

Epidermal growth factor (EGF)-like factors with EGF competing and cell growth stimulating activity were investigated in malignant and nonmalignant tissues. About 37% of ovarian carcinomas present an increased factor activity between 9.0 and 19.3 ng EGF units/mg protein. In one tumor 175.0 ng EGF units/mg protein were found. In extracts of nonmalignant tissues, the factor concentration was about 1.0-6.4 ng EGF units/mg protein. Isoelectric focusing was performed to characterize these factors. In normal ovaries and ovarian carcinomas, factors with EGF competing activity focus at pH 8.0-9.0, pH 5.7-6.3, and pH 3.6-4.9. In ovarian carcinomas, an additional peak with EGF competing and cell growth stimulating activity was found between pH 6.5 and 7.2. Similar results could be achieved in other malignant tissues investigated. These data indicate the presence of EGF-like factors. EGF itself focuses at pH 4.6 (G. Carpenter and S. Cohen, Annu. Rev. Biochem., 48: 193-216, 1979). Specific EGF binding was determined in 12 ovarian carcinomas. In five of these cases EGF receptors could be detected. In the EGF receptor positive carcinomas, the content of EGF-like growth factors varied between 0 and 9 ng EGF units/mg protein. In EGF receptor negative cases, the content of EGF-like growth factors varied between 0 and 19.3 ng EGF units/mg protein. The clinical data of 19 patients are also demonstrated.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3008995

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  5 in total

1.  The occurrence of epidermal growth factor receptors and the characterization of EGF-like factors in human ovarian, endometrial, cervical and breast cancer. EGF receptors and factors in gynecological carcinomas.

Authors:  T Bauknecht; M Kohler; I Janz; A Pfleiderer
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

2.  Human ovarian carcinomas: correlation of malignancy and survival with the expression of epidermal growth factor receptors (EGF-R) and EGF-like factors (EGF-F).

Authors:  T Bauknecht; I Janz; M Kohler; A Pfleiderer
Journal:  Med Oncol Tumor Pharmacother       Date:  1989

3.  Occurrence of epidermal growth factor receptors in benign and malignant ovarian tumors and normal ovarian tissues: an immunohistochemical study.

Authors:  S C Henzen-Logmans; M E van der Burg; J A Foekens; P M Berns; R Brussée; J H Fieret; J G Klijn; S Chadha; C J Rodenburg
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

4.  Growth factors in ovarian cancer.

Authors:  O J Owens; C Stewart; R E Leake
Journal:  Br J Cancer       Date:  1991-12       Impact factor: 7.640

5.  Epidermal growth factor, oestrogen and progesterone receptor expression in primary ovarian cancer: correlation with clinical outcome and response to chemotherapy.

Authors:  G Scambia; P Benedetti-Panici; G Ferrandina; M Distefano; G Salerno; M E Romanini; A Fagotti; S Mancuso
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.